MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$45,711K
Net loss
-$45,440K
Unrealized loss on
available-for-sale investments
-$271K
Loss before income
taxes
-$45,390K
Income tax expense
$50K
Interest income and
other, net
$2,618K
Loss from operations
-$48,008K
Total operating
expenses
$48,008K
Research and development
$41,134K
General and
administrative
$6,874K
Back
Back
Income Statement
source: myfinsight.com
Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. (AVIR)